US Stock MarketDetailed Quotes
ABBV AbbVie
- 201.680
- +1.210+0.60%
Close Nov 5 16:00 ET
- 204.450
- +2.770+1.37%
Pre 06:14 ET
356.40BMarket Cap70.27P/E (TTM)
202.420High198.350Low5.11MVolume200.490Open200.470Pre Close1.03BTurnover0.29%Turnover Ratio74.15P/E (Static)1.77BShares207.32052wk High59.09P/B355.36BFloat Cap131.48552wk Low6.13Dividend TTM1.76BShs Float207.320Historical High3.04%Div YieldTTM2.03%Amplitude20.016Historical Low201.329Avg Price1Lot Size
About AbbVie Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Company Profile
SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
Founded2011
CEOMr. Robert A. Michael
MarketNYSE
Employees50000
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900
Websitehttp://www.abbvie.com
Company Executives
- Name
- Position
- Salary
- Robert A. Michael
- Director and Chief Executive Officer
- 14.44M
- Dr. Thomas J. Hudson, M.D.
- Senior Vice President and Chief Scientific Officer, Global Research
- --
- Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
- Executive Vice President and Chief Operations Officer
- 9.30M
- Timothy J. Richmond
- Executive Vice President and Chief Human Resources Officer
- --
- Scott Reents
- Executive Vice President and Chief Financial Officer
- 10.19M
- Jeffrey Ryan Stewart
- Executive Vice President and Chief Commercial Officer
- 15.35M
- Dr. Roopal Thakkar, M.D.
- Senior Vice President and Chief Medical Officer, Global Therapeutics
- --
- Dr. Nicholas Donoghoe
- Executive Vice President, Chief Business and Strategy Officer
- --
- Kevin K. Buckbee
- Senior Vice President, Controller and Principal Accounting Officer
- --
- Perry C. Siatis
- Executive Vice President, General Counsel and Secretary
- --
- Richard A. Gonzalez
- Chairman of the Board
- 25.66M
- Rebecca B. Roberts
- Independent Director
- 359.98K
- Brett J. Hart
- Independent Director
- 384.98K
- Dr. Susan E. Quaggin, M.D.
- Independent Director
- 24.00K
- Roxanne S. Austin
- Independent Director
- 388.39K
- Jennifer L. Davis
- Independent Director
- 45.00K
- Edward J. Rapp
- Independent Director
- 394.98K
- Thomas C. Freyman
- Independent Director
- 389.98K
- William H.L. Burnside
- Independent Director
- 377.48K
- Frederick H. Waddell
- Independent Director
- 369.98K
- Melody B. Meyer
- Independent Director
- 369.98K
- Dr. Robert J. Alpern,M.D.
- Independent Director
- 461.18K
- Glenn F. Tilton
- Lead Independent Director
- 421.58K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data